Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hologic pacifies US Federal Trade Commission and sells Mammotest to Siemens

This article was originally published in Clinica

Executive Summary

Hologic is to sell all intellectual property relating to its Mammotest prone stereotactic bed breast biopsy systems (SBBS), which the company had recently acquired from Fischer Imaging, to diagnostic imaging rival Siemens Medical Solutions for $6.5m. The move followed a complaint filed last week by the US Federal Trade Commission (FTC), alleging that Hologic's acquisition of Fischer's prone SBBS business gave the former a monopoly in the US market for these devices.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts